Nicotine-containing pharmaceutical compositions giving a rapid transmucosal absorption
US6676959B1 · kind B1 · utility
44Cited by
5References
89Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 11, 2001 |
| Grant date | Jan 13, 2004 |
| Priority date | — |
| Expiry date | Jul 11, 2021 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/34
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Formulations of nicotine for use in nicotine replacement therapy. The formulations are intended for application in the oral cavity where upon the uptake of nicotine mainly takes place through the buccal mucosa. The formulations essentially comprise apolar, polar and surface-active components. The formulations may be administered in combination with other nicotine formulations.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.